SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+5.7%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.45B
AUM Growth
+$2.45B
(+3.4%)
Cap. Flow
+$258M
Cap. Flow
% of AUM
10.51%
Top 10 Holdings %
Top 10 Hldgs %
45.17%
Holding
110
New
9
Increased
24
Reduced
21
Closed
11
Top Buys
| 1 |
UnitedHealth
UNH
|
$74.5M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$41.6M |
| 3 |
Biohaven
BHVN
|
$41.5M |
| 4 |
Apple
AAPL
|
$39.3M |
| 5 |
Sysco
SYY
|
$37.2M |
Top Sells
| 1 |
argenx
ARGX
|
$48M |
| 2 |
Cigna
CI
|
$43.7M |
| 3 |
McKesson
MCK
|
$32M |
| 4 |
Verizon
VZ
|
$23.5M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
$22.8M |
Sector Composition
| 1 | Healthcare | 65.51% |
| 2 | Technology | 11.21% |
| 3 | Communication Services | 6.91% |
| 4 | Consumer Discretionary | 6.1% |
| 5 | Financials | 3.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
McKesson
MCK
$85.9B
| $1.07M | 0.04% |
1,830
-54,809
| -97% | -$32M |
|
77
Protagonist Therapeutics
PTGX
$3.62B
| $1.06M | 0.04% |
30,500
| – | – |
|
78
Edwards Lifesciences
EW
$47.7B
| $1.03M | 0.04% |
11,100
| – | – |
|
79
HCA Healthcare
HCA
$95.4B
| $1.02M | 0.04% |
3,190
| – | – |
|
80
CVS Health
CVS
$93B
| $1.01M | 0.04% |
17,170
| – | – |
|
81
Waters Corp
WAT
$17.3B
| $914K | 0.03% |
3,150
| – | – |
|
82
Illumina
ILMN
$15.2B
| $911K | 0.03% |
8,730
-244
| -3% | -$25.5K |
|
83
Five Below
FIVE
$8.33B
| $833K | 0.03% |
+7,645
| New | +$833K |
|
84
Humana
HUM
$37.5B
| $729K | 0.03% |
1,950
| – | – |
|
85
DexCom
DXCM
$30.9B
| $667K | 0.02% |
5,880
| – | – |
|
86
Agilent Technologies
A
$35.5B
| $647K | 0.02% |
4,990
| – | – |
|
87
Veralto
VLTO
$26.1B
| $523K | 0.02% |
5,475
| – | – |
|
88
Ionis Pharmaceuticals
IONS
$9.64B
| $515K | 0.02% |
10,800
| – | – |
|
89
ResMed
RMD
$39.4B
| $457K | 0.02% |
2,390
| – | – |
|
90
Morgan Stanley
MS
$237B
| $448K | 0.02% |
4,611
-3,030
| -40% | -$294K |
|
91
Zimmer Biomet
ZBH
$20.8B
| $354K | 0.01% |
3,260
| – | – |
|
92
Steris
STE
$23.9B
| $336K | 0.01% |
1,530
| – | – |
|
|
MREO
93
Mereo BioPharma
MREO
$275M
| $270K | 0.01% |
75,000
-3,578,494
| -98% | -$12.9M |
|
94
Baxter International
BAX
$12.1B
| $267K | 0.01% |
7,970
| – | – |
|
95
Align Technology
ALGN
$9.59B
| $266K | 0.01% |
1,100
| – | – |
|
96
Charles River Laboratories
CRL
$7.99B
| $209K | 0.01% |
1,010
| – | – |
|
|
RVNC
97
DELISTED
Revance Therapeutics, Inc.
RVNC
| $150K | 0.01% |
58,425
-1,541,575
| -96% | -$3.96M |
|
|
98
argenx
ARGX
$44.2B
| – | – |
-121,900
| Closed | -$48M |
|
|
BCYC
99
Bicycle Therapeutics
BCYC
$492M
| – | – |
-914,476
| Closed | -$22.8M |
|
100
Cogent Biosciences
COGT
$1.83B
| – | – |
-316,000
| Closed | -$2.12M |
|